1. Clinical importance of DNA repair in sporadic colorectal cancer
   Gustavo A. Laporte et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
2. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
   Fatemeh Ghorbani Parsa et al, 2022, Journal of Personalized Medicine CrossRef
3. Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review
   Emma C. Hulshof et al, 2020, Frontiers in Pharmacology CrossRef
4. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
   Lei Bian et al, 2019, Molecular Cancer CrossRef
5. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer
   Paula Pellenz Tomasini et al, 2021, Cancers CrossRef
6. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
   Yiling Situ et al, 2019, International Journal of Molecular Sciences CrossRef
7. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment
   Lumei Kang et al, 2021, Journal of Neurology CrossRef
8. Dominantly Inherited Hereditary Nonpolyposis Colorectal Cancer Not Caused by MMR Genes
   Mariona Terradas et al, 2020, Journal of Clinical Medicine CrossRef
9. Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy
   Karolina Seborova et al, 2022, Frontiers in Oncology CrossRef
10. High Expression of MRE11A Is Associated with Shorter Survival and a Higher Risk of Death in CRC Patients
    Daniel Azambuja et al, 2023, Genes CrossRef
11. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy
    Alexandra Giatromanolaki et al, 2023, Immunobiology CrossRef
12. Inhibition of DNA-PKcs activity re-sensitizes uveal melanoma cells to radio- and chemotherapy
    Bingjie Zhang et al, 2020, Biochemical and Biophysical Research Communications CrossRef
13. High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas
    Jhen-Hao Jhan et al, 2023, Applied Immunohistochemistry & Molecular Morphology CrossRef
14. LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis
    Mengxin Lin et al, 2021, Human Cell CrossRef
15. MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients
    Josef Horak et al, 2022, Frontiers in Oncology CrossRef
16. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
    Mariam Gachechiladze et al, 2017, International Journal of Cancer CrossRef
17. TOX3 regulates the proliferation and apoptosis of colorectal cancer by downregulating RhoB via the activation of the MAPK pathway
    Wei Yang et al, 2022, Cell Biology International CrossRef
18. Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways
    Leonie Schürmann et al, 2021, Cancer Letters CrossRef
19. Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice
    Angeliki Gkikoudi et al, 2023, Applied Sciences CrossRef
20. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo
    Xiaoni Liu et al, 2017, International Journal of Oncology CrossRef
21. The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond
    Marialaura Petroni et al, 2023, Cancers CrossRef